Chancellor Financial Group WB’s iShares Biotechnology ETF IBB Stock Holding History

Chancellor Financial Group WB’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$494K	Hold	2,599	–	–	0.31%	68
2026 Q1	$439K	Buy	2,599 +1	+0%	+$171	0.31%	65
2025 Q4	$439K	Hold	2,598	–	–	0.3%	64
2025 Q3	$375K	Buy	2,598 +1	+0%	+$136	0.26%	77
2025 Q2	$329K	Hold	2,597	–	–	0.25%	83
2025 Q1	$332K	Buy	2,597 +1	+0%	+$136	0.27%	76
2024 Q4	$343K	Buy	+2,596	New	+$365K	0.28%	73

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Chancellor Financial Group WB's IBB Position: Q2 2026 in Review

Chancellor Financial Group WB held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 2,599 shares worth $494K. The position accounts for 0.31% of the portfolio, ranked #68.

Chancellor Financial Group WB first reported a position in IBB in Q4 2024 and has held it in 7 quarters since. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Chancellor Financial Group WB held 2,599 shares of iShares Biotechnology ETF worth $494K as of Q2 2026.
Chancellor Financial Group WB left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up 0.31% of Chancellor Financial Group WB's portfolio in Q2 2026, its #68 holding.
Chancellor Financial Group WB first reported a position in iShares Biotechnology ETF in Q4 2024 and has held it in 7 quarters since.
956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Chancellor Financial Group WB's 13F filing for Q2 2026, filed 10 Aug 2026.